Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (231-240 of 358) with videos related to

Pageof 36
Sort By:
Neurobiology of Disease|November 17, 2019
Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's diseaseFabian Maass, Bernhard Michalke, Desiree Willkommen, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive DeclineAnna Emdina, Peter Hermann, Daniela Varges, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2016
Doxycycline in early CJD: a double-blinded randomised phase II and observational studyDaniela Varges, Henrike Manthey, Uta Heinemann, et al.
Dementia and Geriatric Cognitive Disorders|April 2, 2005
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseLukas Cepek, Petra Steinacker, Brit Mollenhauer, et al.
Biomedicines|June 27, 2024
SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal DementiaAthanasia Chatziefstathiou, Sezgi Canaslan, Eirini Kanata, et al.
Neurogenetics|March 19, 2008
Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutationAna B Rodríguez-Martínez, Miguel A Alfonso-Sánchez, José A Peña, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 9, 2018
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob diseaseNiels Kruse, Amanda Heslegrave, Vandana Gupta, et al.
Emerging Infectious Diseases|January 1, 2014
Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob diseaseJean Yves Douet, Saima Zafar, Armand Perret-Liaudet, et al.
Acta Neuropathologica|June 25, 2020
SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's diseaseNeelam Younas, Saima Zafar, Mohsin Shafiq, et al.
Plos One|February 2, 2013
Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assayKazunori Sano, Katsuya Satoh, Ryuichiro Atarashi, et al.
Pageof 36

Showing results (231-240 of 358) with videos related to

Sort By:
Pageof 36
Neurobiology of Disease|November 17, 2019
Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's diseaseFabian Maass, Bernhard Michalke, Desiree Willkommen, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive DeclineAnna Emdina, Peter Hermann, Daniela Varges, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2016
Doxycycline in early CJD: a double-blinded randomised phase II and observational studyDaniela Varges, Henrike Manthey, Uta Heinemann, et al.
Dementia and Geriatric Cognitive Disorders|April 2, 2005
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseLukas Cepek, Petra Steinacker, Brit Mollenhauer, et al.
Biomedicines|June 27, 2024
SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal DementiaAthanasia Chatziefstathiou, Sezgi Canaslan, Eirini Kanata, et al.
Neurogenetics|March 19, 2008
Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutationAna B Rodríguez-Martínez, Miguel A Alfonso-Sánchez, José A Peña, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 9, 2018
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob diseaseNiels Kruse, Amanda Heslegrave, Vandana Gupta, et al.
Emerging Infectious Diseases|January 1, 2014
Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob diseaseJean Yves Douet, Saima Zafar, Armand Perret-Liaudet, et al.
Acta Neuropathologica|June 25, 2020
SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's diseaseNeelam Younas, Saima Zafar, Mohsin Shafiq, et al.
Plos One|February 2, 2013
Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assayKazunori Sano, Katsuya Satoh, Ryuichiro Atarashi, et al.
Pageof 36